KR840000514A - 벤조일- 페닐- 피페리딘 유도체의 제법 - Google Patents

벤조일- 페닐- 피페리딘 유도체의 제법 Download PDF

Info

Publication number
KR840000514A
KR840000514A KR1019820002891A KR820002891A KR840000514A KR 840000514 A KR840000514 A KR 840000514A KR 1019820002891 A KR1019820002891 A KR 1019820002891A KR 820002891 A KR820002891 A KR 820002891A KR 840000514 A KR840000514 A KR 840000514A
Authority
KR
South Korea
Prior art keywords
group
compound
different
same
alkyl group
Prior art date
Application number
KR1019820002891A
Other languages
English (en)
Other versions
KR880001298B1 (ko
Inventor
베르나르 마느와 (외 3)
Original Assignee
프랑소와 삐꺄르
쏘시에떼 드 르쉐르쉬 엥뒤스트리엘르(쎄.오.에르.이)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프랑소와 삐꺄르, 쏘시에떼 드 르쉐르쉬 엥뒤스트리엘르(쎄.오.에르.이) filed Critical 프랑소와 삐꺄르
Publication of KR840000514A publication Critical patent/KR840000514A/ko
Application granted granted Critical
Publication of KR880001298B1 publication Critical patent/KR880001298B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

벤조일-페닐-피페리딘 유도체의 제법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. ⅰ) 하기식(Ⅲ)의 2-할로게노-5-니트로-벤조페놀을 하기식(Ⅱ)의 치환 피리딘과 반응시켜 하기식(I0)의 니트로 화합물을 얻고, ⅱ) 상기에서 수득된 화합물(I0)의 니트로기를 아미노기로 환원시켜 R4=NH2인 식(Ⅰ)의 아미노 유도체를 얻은 다음, 상기 아미노 유도체를 탈아미노기, 알킬화 또는 아미노기를 할로겐기로 전환시키는 반응을 시킴을 특징으로 하는 하기식(Ⅰ)의 2-피페리디노벤조페논류로 구성된 군으로부터 선택된 신규벤조일-페닐-피페리딘 유도체 및 그의 산부가염의 제조방법.
    상기 식에서;
    -R1,R2및 R3는 동일 또는 상이한데, 각각 수소원자, 히드록시기, CF3, 할로겐, 저급알킬기 또는 저급알콕시기이고; -R4는 수소원자, 할로겐, NO2기, NR'R"기[여기서, R' 및 R"는 동일 또는 상이하며, 수소원자, 저급알킬기 또는 CO2R기(R은 저급알킬기 또는 벤질기를 나타냄)]이고; -R5및 R6는 동일 또는 상이하며 각각 수소원자, 저급알킬기, OH기, 페닐기 또는 벤질기이고; -X는 할로겐원자(바람직하기는 Cl 또는 F)이다.
  2. 제1항에 있어서, 반응단계 ⅰ) 이 화합물(Ⅲ) 1.1몰 대 화합물(Ⅱ) 1몰 비율로 15℃ 내지 반응 매질의 환류 온도사이의 온도에서 염기 존재하, 특히 방향족 탄화수소류, 에테르류 및 알코올류로 구성된 군으로부터 선택된 불활성 유기 용매중에서 수행됨을 특징으로 하는 방법.
  3. 제1항에 있어서, 니트로기의 환원반응 단계 ⅱ)가 15℃ 내지 반응 매질의 환류온도 사이의 온도에서철 및 산존재하, 특히 알코올 및 알코올-물의 혼합물로 이루어진 군으로부터 선택된 불활성 유기용매 중에서 행해짐을 특징으로하는 방법.
  4. 제1항에 있어서 0℃에서 아질산나트륨 또는 아질산 칼륨으로 상기 아미노기를 디아조화시킨 다음, 생성된 디아조늄기를 수소원자, 할로겐원자 또는 CF3기로 공지의 메카니즘에 따라 치환시킴으로써 아미노기의 탈아미노 기화 단계 ⅱ)가 행해짐을 특징으로 하는 방법.
  5. 제1항에 있어서, -R1,R2및 R3가 동일 또는 상이하며 각각 H,F, Cl,Br,OH,CF3,C1~C4-알킬기 또는 C1~C4-알콕시기이며; -R4는 H,Cl,Br,F 또는 NR'R"[여기서, R' 및 R"는 동일 또는 상이하며, H,C1~C4-알킬기 또는 CO2R기(여기서, R은 C1~C4-알킬기 또는 벤질기임)을 나타냄]이고; -R5및 R6는 동일 또는 상이하며 각각 H, C1~C4알킬기, OH기, 페닐기 또는 벤질기임을 특징으로 하는방법.
  6. 제1항에 있어서, -R1,R2및 R3가 동일 또는 상이하며 각각 H,F,Cl,Br,OH,CF3,C1~C4-알킬기 또는 C1~C4-알콕시기를 나타내며; -R4는 H,Cl,Br,F,NO2또는 NR'R"[여기서, R' 및 R"는 동일 또는 상이하며 H,C1~C|4-알킬기 또는 CO2R기(여기서, R은 C1~C4-알킬기 또는 벤질기임)을 나타냄]기이며; -R5및 R6는 동일 또는 상이하며 각각 H,C1~C4알킬기, OH기, 페닐기 또는 벤질기를 나타내고; -R1,R2,R3,R4,R5및 R6은 하기 2가지 조선(A) 및 (B)[(A)-R1,R2,R3,R4,R5및 R6중의 하나 이상은 수소가 아님 (B) R1=R2=R3=R5=R6=H인 경우 R4는 NO2가 아님]중 하나 이상의 조건에 따라야 함을 특징으로 하는 방법.
  7. 제1 또는 2항에 있어서, R1=4-Cl; R=NO2; R5=4-CH3; 그리고 R2=R5=R6=H인 방법.
  8. 제1 또는 3항에 있어서, R1=4-Cl; R4=NH2; R5=4-CH3; 그리고 R2=R3=R6=H인 방법.
  9. 제1 또는 3항에 있어서, R1=4-Cl; R4=NH2; R5=3-CH3; 그리고 R2=R3=R6=H인 방법.
  10. 제1 또는 3항에 있어서, R1=4-Cl; R4=NH2; R5=2-CH3; 그리고 R2=R3=R6=H인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR8202891A 1981-06-29 1982-06-29 벤조일-페닐-피페리딘 유도체의 제법 KR880001298B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8112745A FR2508445A1 (fr) 1981-06-29 1981-06-29 Nouveaux derives de benzoyl-phenyl-piperidine, leur procede de preparation et leur application, notamment en therapeutique
FR8112745 1981-06-29

Publications (2)

Publication Number Publication Date
KR840000514A true KR840000514A (ko) 1984-02-22
KR880001298B1 KR880001298B1 (ko) 1988-07-22

Family

ID=9259970

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8202891A KR880001298B1 (ko) 1981-06-29 1982-06-29 벤조일-페닐-피페리딘 유도체의 제법

Country Status (26)

Country Link
US (2) US4528294A (ko)
EP (1) EP0069012B1 (ko)
JP (1) JPS588061A (ko)
KR (1) KR880001298B1 (ko)
AR (1) AR230048A1 (ko)
AT (1) ATE9795T1 (ko)
AU (1) AU550320B2 (ko)
CA (1) CA1187501A (ko)
CS (1) CS235542B2 (ko)
DD (1) DD202557A5 (ko)
DE (1) DE3260949D1 (ko)
DK (1) DK152668C (ko)
ES (1) ES8304936A1 (ko)
FI (1) FI77447C (ko)
FR (1) FR2508445A1 (ko)
GR (1) GR76401B (ko)
HU (1) HU189150B (ko)
IE (1) IE53189B1 (ko)
IL (2) IL66123A (ko)
NO (1) NO160136C (ko)
OA (1) OA07133A (ko)
PH (1) PH17368A (ko)
PT (1) PT75135B (ko)
SU (1) SU1147251A3 (ko)
YU (1) YU43799B (ko)
ZA (1) ZA824536B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL82573A0 (en) * 1986-05-30 1987-11-30 Sori Soc Rech Ind Preparation of benzoylphenyl-piperidine derivatives
FR2620027A1 (fr) * 1987-09-09 1989-03-10 Fournier Innovation Synergie Nouvelle utilisation de la (5-amino-2-(4-methyl-1-piperidinyl)phenyl)-(4-chlorophenyl)-methanone
WO2000071519A2 (en) * 1999-05-21 2000-11-30 Eli Lilly And Company Immunopotentiator agents
JP2003528830A (ja) * 2000-03-10 2003-09-30 ファルマシア・コーポレーション テトラヒドロベンゾチエピン類の製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202655A (en) * 1962-04-27 1965-08-24 Yvon G Perron 6-[alpha-substituted-alpha-(2-or 3-heterocyclic) acetamido] penicillanic acid and nontoxic salts thereof
BE637329A (ko) * 1962-11-13
FR1375300A (fr) * 1962-11-13 1964-10-16 Hoffmann La Roche Dérivés de benzophénone et leur préparation
FR1403939A (fr) * 1963-06-07 1965-06-25 Hoffmann La Roche Procédé pour la préparation de dérivés de benzodiazépine
FR1526708A (fr) * 1966-06-13 1968-05-24 Upjohn Co 1.3-amino-alcools, leurs intermédiaires et dérivés et leur procédé de préparation
US3668199A (en) * 1966-06-13 1972-06-06 Upjohn Co 1,3-aminoalcohols
FR1530393A (fr) * 1966-07-11 1968-06-21 Hoffmann La Roche Procédé pour la préparation de dérivés de pipéridine
IE34545B1 (en) * 1969-10-01 1975-06-11 Continental Pharma Amino-alcohols,their salts and process for preparing the same
HU167950B (ko) * 1973-07-26 1976-01-28
HU167949B (ko) * 1973-07-26 1976-01-28
US4064121A (en) * 1973-07-26 1977-12-20 Richter Gedeon Vegyeszeti Gyar Rt. Substituted nitrobenzophenone derivatives and a process for the preparation thereof
US4021563A (en) * 1975-02-06 1977-05-03 Sven Eric Harry Hernestam Method of treating cardiac arrhythmia with γ-piperidino-butyrophenones
IE49998B1 (en) * 1979-08-06 1986-01-22 Merrell Dow Pharma 4-(naphthalenyloxy)piperidine derivatives

Also Published As

Publication number Publication date
FR2508445B1 (ko) 1984-02-10
DK152668C (da) 1988-09-19
FI822215A0 (fi) 1982-06-21
JPS588061A (ja) 1983-01-18
US4528294A (en) 1985-07-09
JPH0127062B2 (ko) 1989-05-26
CA1187501A (en) 1985-05-21
NO160136C (no) 1989-03-15
IL66123A0 (en) 1982-09-30
HU189150B (en) 1986-06-30
PT75135B (fr) 1984-05-25
EP0069012B1 (fr) 1984-10-10
IE53189B1 (en) 1988-08-17
DE3260949D1 (en) 1984-11-15
ES513565A0 (es) 1983-03-16
ES8304936A1 (es) 1983-03-16
GR76401B (ko) 1984-08-10
AU8542982A (en) 1983-01-06
KR880001298B1 (ko) 1988-07-22
DD202557A5 (de) 1983-09-21
DK152668B (da) 1988-04-11
OA07133A (fr) 1984-03-31
PT75135A (fr) 1982-07-01
IL76287A0 (en) 1986-01-31
CS235542B2 (en) 1985-05-15
PH17368A (en) 1984-08-06
NO160136B (no) 1988-12-05
ZA824536B (en) 1983-04-27
IE821475L (en) 1982-12-29
US4680402A (en) 1987-07-14
NO822185L (no) 1982-12-30
FI77447B (fi) 1988-11-30
ATE9795T1 (de) 1984-10-15
SU1147251A3 (ru) 1985-03-23
YU141582A (en) 1985-03-20
DK289382A (da) 1982-12-30
AR230048A1 (es) 1984-02-29
EP0069012A1 (fr) 1983-01-05
FR2508445A1 (fr) 1982-12-31
AU550320B2 (en) 1986-03-20
FI77447C (fi) 1989-03-10
YU43799B (en) 1989-12-31
IL66123A (en) 1986-02-28
FI822215L (fi) 1982-12-30

Similar Documents

Publication Publication Date Title
KR830010077A (ko) 벤자제핀 유도체의 제조방법
KR870003989A (ko) 치환 및 이치환 피리딘-2,3-디카르복실레이트의 제조방법과 치환된 니코티네이트의 제조방법
KR920701104A (ko) α, β-불포화 케톤의 제조방법
KR880000364A (ko) (2,2)-파라시클로판 및 그의 유도체 제조방법
KR840000508A (ko) 4-아닐리노피리미딘 유도체의 제조방법
KR840001145A (ko) 피리다진의 아미노 화합물의 제조방법
KR830007571A (ko) 8-아릴알킬-3-페닐-3-노르트로판올의 제조방법
KR830002699A (ko) 신규의 안트라센-9,10-비스-카르보닐-히드라존 및 그 유도체 제조방법
BR9812873B1 (pt) processo para preparar derivados de triazolinationa.
KR840000514A (ko) 벤조일- 페닐- 피페리딘 유도체의 제법
KR960014271A (ko) 디아릴디케토피롤로피롤 안료의 제조 방법
KR840001555A (ko) 치환된 2-페닐-2-(피리딜욕시)-에틸아민과 그의 등 배전자화합물 및 그들의 산부가염을 제조하는 방법
KR840000481A (ko) 페녹시벤조산으로 부터 유도된 제초성 화합물의 제조방법
KR840000556A (ko) 5,6,7,7a-테트라하이드로-4H-티에노(3,2-c)-피리딘-2-온 유도체의 제조방법
US3775442A (en) Process for the manufacture of a triarylmethane compound
KR840008647A (ko) 대칭 1,4-디하이드로피리딘디카복실 에스테르의 제조방법
KR830008484A (ko) 제초 조성물
KR860001071A (ko) 퀴놀론-및 나프티리돈-카르복실산의 제조방법
KR960010613A (ko) 2,4-이중치환된 페놀과 2-니트로아닐린의 아조 커플링
KR860000268A (ko) N-벤조일-n'-피리미디닐옥시페닐 우레아 화합물류의 제조방법
KR920002518A (ko) P-위치에서 c₁-c₄알콕시에 의해 치환된 방향족 아민의 제조방법
KR850004583A (ko) 페닐아세트아닐리드 유도체의 제조방법
KR910016673A (ko) 히드록시페닐프로피오네이트의 제조방법
KR840000480A (ko) 페녹시 벤조산류에서 유도된 제초제 화합물류의 제조방법
KR940014300A (ko) 2,5-디메톡시-4-할로아닐린의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
N231 Notification of change of applicant
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19910628

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee